KR830006231A - 벤즈아졸 유도체의 제조방법 - Google Patents
벤즈아졸 유도체의 제조방법 Download PDFInfo
- Publication number
- KR830006231A KR830006231A KR1019810001768A KR810001768A KR830006231A KR 830006231 A KR830006231 A KR 830006231A KR 1019810001768 A KR1019810001768 A KR 1019810001768A KR 810001768 A KR810001768 A KR 810001768A KR 830006231 A KR830006231 A KR 830006231A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- general formula
- salt
- optionally
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (1)
- 일반식(Ⅱ) 및 (Ⅲ)화합물 또는 이의 염을 서로 축합시키거나, 일반식(Ⅳ)화합물 또는 이의 염에서 Y5를 일빈식 R1-C=X1)-으로 전환하거나 일반식(Ⅴ)화합물 또는 이의 염을 폐환하고 경우에 따라 본 발명에 ㄸ라ㅏ 수득되는 화합물을 일반식(Ⅰ)의 다른 화합물로 전환하고 및/또는 본 발명에 따라 수득되는 염을 유리 화합물 또는 다른 염으로전환시킴을 특징으로 하여 일반식(Ⅰ)의 다른 화합물로 전환하고/및 또는 본 발명에 따라 수득되는 염을 유리 화합물 또는다른 염으로 전환시킴을 특징으로 하여 일반식(Ⅰ)의 벤즈아졸유도체 또는 이의 염, 특히 약학적으로 무독한 이의 염을 제조하는 방법.R1는 임의로 4-치환된 피페라지노그룹 또는 일반식 R2-알크-X2-의 그룹이고R2는임의로 에스테르화된 카복시 또는 하이드록시 메틸이고, "알크"는 저급알킬렌 또는 저급알킬렌 또는 저급알킬리덴이고X1및 X2는 각기 산소 또는 황이고Ph는 R1-C(=X1)-NH-에 의해 임의로 치환된 1,2-페닐렌이고X3는 산소, 황 또는 임의로 치횐된 이미노이고R5- 임의로 불소-치환된 저급알킬 또는 사이클로 알킬이고,Y1은 수소이고Y2및 Y3는 함께 일반식 =C=X1의 그룹이거나 Y1및 Y2의 하나가 일반식 R1-C(=X1)-Y4이면(여기에서 Y4는 제거될 수 있는 그룹임) 다른 하나오 Y3는 수소이거나 R1이 일반식 R2-알크-X2-의 그룹인 경우 Y1은 시이노이고 Y2및 Y3는 수소이고,Y5는 일반식 R1-C(=X1)- 그룹으로 전환될 수 있는 기이고Y11및 Y12의 하나가 일반식 -C(=Y13)-R5- 그룹이면 다른 하나는 분리될 수 있는 기이고Y13은 임의로 기능적으로 변형된 옥소이다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH401680 | 1980-05-22 | ||
CH4016/80-7 | 1980-05-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR830006231A true KR830006231A (ko) | 1983-09-20 |
KR850000555B1 KR850000555B1 (ko) | 1985-04-26 |
Family
ID=4268232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019810001768A KR850000555B1 (ko) | 1980-05-22 | 1981-05-21 | 벤즈아졸 유도체의 제조방법 |
Country Status (28)
Country | Link |
---|---|
US (1) | US4511567A (ko) |
EP (1) | EP0041046B1 (ko) |
JP (1) | JPS5718670A (ko) |
KR (1) | KR850000555B1 (ko) |
AU (1) | AU547922B2 (ko) |
CY (1) | CY1339A (ko) |
DD (1) | DD159073A5 (ko) |
DE (1) | DE3176402D1 (ko) |
DK (1) | DK164786C (ko) |
ES (3) | ES8300724A1 (ko) |
FI (1) | FI75564C (ko) |
GB (1) | GB2076399B (ko) |
GR (1) | GR75253B (ko) |
HK (1) | HK74686A (ko) |
HU (1) | HU186770B (ko) |
IE (1) | IE52426B1 (ko) |
IL (1) | IL62928A (ko) |
IN (1) | IN153293B (ko) |
KE (1) | KE3645A (ko) |
MA (1) | MA19290A1 (ko) |
MW (1) | MW2181A1 (ko) |
MY (1) | MY8700141A (ko) |
OA (1) | OA06816A (ko) |
PH (1) | PH16754A (ko) |
PT (1) | PT73066B (ko) |
ZA (1) | ZA8103409D (ko) |
ZM (1) | ZM4481A1 (ko) |
ZW (1) | ZW11981A1 (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8423697D0 (en) * | 1984-09-19 | 1984-10-24 | Ciba Geigy Ag | Benzazole derivatives |
US5246927A (en) * | 1988-08-17 | 1993-09-21 | Ciba-Geigy Corporation | Benzazole derivatives, processes for their preparation containing such compounds and the use thereof |
ES2145743T3 (es) * | 1990-12-28 | 2000-07-16 | Teijin Ltd | Compuesto de anillo condensado benzoxa, su produccion y composicion farmaceutica que lo contiene. |
AU2962397A (en) * | 1996-06-07 | 1998-01-07 | Novartis Ag | Benzazole derivatives |
US6177572B1 (en) * | 1997-08-20 | 2001-01-23 | Sepracor, Inc. | Solid and liquid-phase synthesis of benzoxazoles and benzothiazoles and their use |
EP3235815A1 (de) * | 2016-04-19 | 2017-10-25 | Philipps-Universität Marburg | Wirkstoffe gegen parasitäre helminthen |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1087561A (en) * | 1963-02-16 | 1967-10-18 | Fisons Pest Control Ltd | Fluorinated benzimidazoles and compositions containing them |
IE31812B1 (en) * | 1967-02-03 | 1973-01-10 | Merck & Co Inc | Benzimidazole derivatives |
US3646049A (en) * | 1970-03-05 | 1972-02-29 | Merck & Co Inc | Acylaminobenzimidazole derivatives |
US3714180A (en) * | 1970-08-12 | 1973-01-30 | Squibb & Sons Inc | Sulfonyl benzimidazoles |
BE792402A (fr) * | 1971-12-07 | 1973-06-07 | Ciba Geigy | Composes heterocycliques azotes et medicaments anthelminthiqueset antimicrobiens qui en contiennent |
-
1981
- 1981-05-11 MA MA19351A patent/MA19290A1/fr unknown
- 1981-05-12 IN IN500/CAL/81A patent/IN153293B/en unknown
- 1981-05-18 GB GB8115153A patent/GB2076399B/en not_active Expired
- 1981-05-18 CY CY1339A patent/CY1339A/xx unknown
- 1981-05-18 FI FI811531A patent/FI75564C/fi not_active IP Right Cessation
- 1981-05-18 EP EP81810187A patent/EP0041046B1/de not_active Expired
- 1981-05-18 DE DE8181810187T patent/DE3176402D1/de not_active Expired
- 1981-05-20 ES ES502355A patent/ES8300724A1/es not_active Expired
- 1981-05-20 MW MW21/81A patent/MW2181A1/xx unknown
- 1981-05-20 GR GR65012A patent/GR75253B/el unknown
- 1981-05-20 ZM ZM44/81A patent/ZM4481A1/xx unknown
- 1981-05-20 ZW ZW119/81A patent/ZW11981A1/xx unknown
- 1981-05-21 HU HU811487A patent/HU186770B/hu not_active IP Right Cessation
- 1981-05-21 KR KR1019810001768A patent/KR850000555B1/ko active
- 1981-05-21 ZA ZA19813409D patent/ZA8103409D/xx unknown
- 1981-05-21 IE IE1127/81A patent/IE52426B1/en not_active IP Right Cessation
- 1981-05-21 DK DK224381A patent/DK164786C/da not_active Application Discontinuation
- 1981-05-21 IL IL62928A patent/IL62928A/xx not_active IP Right Cessation
- 1981-05-21 DD DD81230154A patent/DD159073A5/de not_active IP Right Cessation
- 1981-05-21 AU AU70910/81A patent/AU547922B2/en not_active Ceased
- 1981-05-21 PT PT73066A patent/PT73066B/pt not_active IP Right Cessation
- 1981-05-21 PH PH25662A patent/PH16754A/en unknown
- 1981-05-22 JP JP7682081A patent/JPS5718670A/ja active Granted
- 1981-05-22 OA OA57409A patent/OA06816A/xx unknown
-
1982
- 1982-06-16 ES ES513169A patent/ES8406452A1/es not_active Expired
- 1982-06-16 ES ES513170A patent/ES8308316A1/es not_active Expired
- 1982-09-16 US US06/418,955 patent/US4511567A/en not_active Expired - Fee Related
-
1986
- 1986-06-09 KE KE3645A patent/KE3645A/xx unknown
- 1986-10-02 HK HK746/86A patent/HK74686A/xx unknown
-
1987
- 1987-12-30 MY MY141/87A patent/MY8700141A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR850001905A (ko) | 벤조시클로 알칸 유도체의 제조방법 | |
KR840000563A (ko) | 세펨 화합물의 제조방법 | |
KR830006231A (ko) | 벤즈아졸 유도체의 제조방법 | |
KR830007626A (ko) | 2-(1,4-벤조디옥산-2-일알킬) 이미다졸류의 제조방법 | |
KR850004754A (ko) | 3-인돌 카르복사미드 화합물류의 제조방법 | |
KR830007683A (ko) | 7β-[2-(2-아미노-4-티아졸릴)-2-(신)-메톡시 아미노 아세트 아미도]-3-세펨-4-카복실산의 에스테르의 제조방법 | |
KR860001045A (ko) | 메발로노락톤의 나프틸 동족체의 제조방법 | |
KR840001152A (ko) | 신규 복소환(複素環) 화합물의 제법 | |
KR850007257A (ko) | 테트라 하이드로 퀴놀린-1-알카보닐 이미다졸 유도체의 제조방법 | |
KR850002460A (ko) | 카르바메이트 화합물의 제조방법 | |
KR860001102A (ko) | 디히드로오로트산 유도체의 제조방법 | |
KR880012579A (ko) | 니트로 에텐 유도체의 제조방법 | |
KR850004470A (ko) | 유기 화합물의 제조방법 | |
KR850001766A (ko) | 무라밀디펩타이드 활성 에스테르 유도체의 제조방법 | |
KR850002979A (ko) | 1,2,3-트리티안화합물의 신규 제조방법 | |
KR840000578A (ko) | 포스포리피드 유도체의 제조방법 | |
KR830002692A (ko) | 카복실산 하이드라자이드류의 제조방법 | |
KR850002467A (ko) | 6-설폭시페놀 유도체의 제조방법 | |
KR870003093A (ko) | 퀴놀론카복실산 유도체의 제조방법 | |
KR830005193A (ko) | 5-설파모일-오르타닐산의 제조방법 | |
KR890002178A (ko) | 신규한 세펨 화합물 | |
KR860006461A (ko) | 항알레르기 작용을 갖는 화합물의 제조방법 | |
KR890016032A (ko) | 푸란 유도체의 제조방법 | |
KR890002177A (ko) | 신규한 세펨 화합물 | |
KR890002176A (ko) | 신규한 세펨 화합물 |